CD70-targeted CAR-T cell therapy incorporating TLR2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD70-targeted CAR-T cell therapy incorporating TLR2, covering 2025-08-11 to 2025-08-11. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of a Novel Humanized CD70-Targeted CAR-T Cell Incorporating TLR2 for Advanced Renal Cell Carcinoma Therapy [EARLY_Phase 1]